Assessing and Addressing Cardiovascular and Obstetric Risks in Patients Undergoing Assisted Reproductive Technology
Published: January 15, 2025
- The World Health Organization (WHO) found that 1 in 6 adults worldwide experience infertility, and data indicate that 1 in 7 individuals in the United States are sub-fertile, meaning they have difficulty getting pregnant or sustaining a pregnancy.
- Assisted reproductive technology (ART) is increasingly utilized to help individuals achieve pregnancy or preserve fertility.
- This statement provides guidance for cardiovascular clinicians caring for those contemplating ART because of what is currently known now in the literature.
Video: Assessing and Addressing Cardiovascular and Obstetric Risks in Patients Undergoing Assisted Reproductive Technology
Rina Mauricio, MD and Arthur Jason Vaught, MD announce the publication of the new scientific statement, discuss the ART process, associated risks, and the importance of a multidisciplinary team in evaluating and managing the long-term health of these patients.
Supporting Materials
- Commentary: Risk Assessment for Patients Considering Assisted Reproductive Technology by Anna Grodzinsky, MD, MSc; Jennifer Kawwass, MD
- Top Things to Know: Assessing and Addressing Cardiovascular and Obstetric Risks in Patients Undergoing Assisted Reproductive Technology
- Opportunities in the Postpartum Period to Reduce Cardiovascular Disease Risk After Adverse Pregnancy Outcomes
- Cardiovascular Disease Risk Factors in Women: The Impact of Race and Ethnicity